News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,737 Results
Type
Article (8234)
Company Profile (142)
Press Release (479360)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167213)
Career Advice (325)
Deals (25812)
Drug Delivery (7)
Drug Development (53234)
Employer Resources (14)
FDA (9822)
Job Trends (8698)
News (239081)
Policy (17987)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (506)
Accelerated approval (28)
ADA (18)
Adcomms (1)
Allergies (99)
Alliances (33271)
ALS (108)
Alzheimer's disease (987)
Antibody-drug conjugate (ADC) (291)
Approvals (10470)
Artificial intelligence (337)
ASCO (165)
Autoimmune disease (222)
Automation (33)
Bankruptcy (263)
Belgium (1)
Best Places to Work (7083)
BIO (37)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (18)
Biotechnology (90)
Bispecific (1)
Bladder cancer (158)
Brain cancer (31)
Breast cancer (523)
Cancer (3861)
Cardiovascular disease (226)
Career advice (258)
Career pathing (3)
CAR-T (183)
CDC (1)
CDMO (23)
Celiac Disease (1)
Cell therapy (498)
Cervical cancer (35)
Clinical research (48311)
Collaboration (1285)
Commercialization (3)
Compensation (1533)
Complete response letters (34)
COVID-19 (795)
CRISPR (64)
C-suite (804)
Cystic fibrosis (87)
Data (5908)
Decentralized trials (1)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (355)
Diagnostics (4257)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (171)
Earnings (73870)
Editorial (2)
Employer branding (2)
Employer resources (15)
Events (88296)
Executive appointments (713)
FDA (12570)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (947)
Gene editing (126)
Generative AI (11)
Gene therapy (337)
GLP-1 (295)
Government (958)
Grass and pollen (2)
Guidances (283)
Healthcare (9414)
Hematology (97)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (107)
Immuno-oncology (61)
Indications (166)
Infectious disease (987)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (261)
Interviews (45)
IPO (12418)
IRA (2)
Job creations (1982)
Job search strategy (245)
JPM (2)
Kidney cancer (17)
Labor market (1)
Layoffs (63)
Leadership (1)
Legal (5198)
Licensing (18)
Liver cancer (48)
Longevity (20)
Lung cancer (553)
Lymphoma (270)
Machine learning (30)
Management (4)
Manufacturing (566)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8701)
Medtech (8860)
Mergers & acquisitions (14461)
Metabolic disorders (728)
mRNA (77)
Multiple sclerosis (108)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (40)
Neuroscience (1874)
NextGen: Class of 2026 (3172)
Non-profit (853)
Now hiring (1)
Obesity (232)
Opinion (13)
Ovarian cancer (168)
Pain (177)
Pancreatic cancer (207)
Parkinson's disease (206)
Partnered (12)
Patents (497)
Patient recruitment (534)
Patient selection (2)
Peanut (32)
People (41449)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15582)
Phase 2 (21544)
Phase 3 (14612)
Pipeline (7732)
Policy (18)
Postmarket research (1576)
Preclinical (6581)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (592)
Real estate (3056)
Recruiting (6)
Regenerative medicine (2)
Regulatory (15032)
Reports (24)
Research institute (608)
Resumes & cover letters (49)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (6)
Startups (2035)
Stomach cancer (3)
Supply chain (51)
Vaccines (345)
Venture capital (17)
Weight loss (75)
Women's health (88)
Worklife (1)
Date
Today (29)
Last 7 days (289)
Last 30 days (1413)
Last 365 days (19171)
2026 (13690)
2025 (19356)
2024 (23114)
2023 (26666)
2022 (34759)
2021 (37363)
2020 (33649)
2019 (23370)
2018 (17564)
2017 (18868)
2016 (17998)
2015 (24328)
2014 (21740)
2013 (18200)
2012 (20294)
2011 (20496)
2010 (20374)
Location
Africa (233)
Alabama (77)
Alaska (2)
Arizona (311)
Arkansas (11)
Asia (18136)
Australia (2135)
California (12372)
Canada (3240)
China (555)
Colorado (497)
Connecticut (427)
Delaware (234)
Europe (25102)
Florida (1854)
Georgia (393)
Hawaii (3)
Idaho (47)
Illinois (726)
India (53)
Indiana (328)
Iowa (16)
Japan (426)
Kansas (106)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1233)
Massachusetts (8123)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2770)
New Mexico (13)
New York (2899)
North Carolina (1317)
North Dakota (4)
Northern California (6227)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2298)
Puerto Rico (21)
Rhode Island (30)
South America (410)
South Carolina (78)
South Dakota (1)
Southern California (5141)
Tennessee (125)
Texas (2006)
United States (40186)
Utah (372)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (959)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
487,737 Results for "cytomed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
October 15, 2025
·
5 min read
Press Releases
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
November 19, 2025
·
5 min read
Press Releases
CytomX Therapeutics to Present at Upcoming September 2026 Investor Conferences
September 1, 2026
·
2 min read
Press Releases
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
November 7, 2025
·
5 min read
Press Releases
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
August 3, 2026
·
3 min read
Press Releases
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
August 27, 2026
·
5 min read
Press Releases
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
·
2 min read
Press Releases
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
August 6, 2026
·
13 min read
Press Releases
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
July 27, 2026
·
3 min read
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
CytoMed Therapeutics Limited has obtained board approval to launch, subject to certain terms and conditions, a pilot program to isolate and cryo-store peripheral blood mononuclear cells for and as a reward to loyal shareholders of CytoMed on a complimentary basis.
March 18, 2024
·
9 min read
1 of 48,774
Next
